JAZZ

Q: What is the price of Jazz Pharmaceuticals (JAZZ) today?

The current price of Jazz Pharmaceuticals (JAZZ) is $ 239.01, representing a 115.29% gain over the past year. The stock began the year trading around $ 170.00 and is currently priced at $ 239.01. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Jazz Pharmaceuticals (JAZZ) pay dividends?

Jazz Pharmaceuticals (JAZZ) did not pay dividends over the past year.

Jazz Pharmaceuticals PLC

Price

$ 239.01

return (12m)

115.29%

p/e

482.61

p/bv

3.14

DIVIDEND YIELD

0.00%

JAZZ price

JAZZ

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment JAZZ

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

17.99%

3 months

40.93%

1 year

115.29%

2 years

120.04%

5 years

32.78%

10 years

0.00%

Fundamentals JAZZ

review the fundamentals of Jazz Pharmaceuticals shares

P/E

482.61

Sector: -3.71 Industry: -3.71

P/S (PSR)

3.21

Sector: -4.14 Industry: -4.14

P/BV

3.14

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.25%

Sector: -63.73% Industry: -63.73%

ROE

0.65%

Sector: -64.07% Industry: -64.07%

ROIC

15.23%

Sector: -2,605.25% Industry: -2,605.25%

NET MARGIN

0.66%

Sector: -39.40% Industry: -39.40%

GROSS MARGIN

88.00%

Sector: 37.14% Industry: 37.14%

OPERATING MARGIN

20.50%

Sector: -38.64% Industry: -38.64%

EV/EBITDA

21.08

Sector: -3.81 Industry: -3.81

EV/EBIT

-378.51

Sector: -3.88 Industry: -3.88

PRICE-TO-ASSETS

1.20

Sector: 1.42 Industry: 1.42

BVPS

73.10

Sector: 1.96 Industry: 1.96

EPS

0.48

Sector: -2.09 Industry: -2.09

EQUITY-TO-ASSETS RATIO

0.38

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.62

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

7.48%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Jazz Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 239.01

Fair Value

$ 0.00

Upside/Downside Return potential.

-88.24%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals JAZZ

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.06	6.75	25.92%	2.28%	$ 548.24 B	21.83%
PFE	18.93	1.57	8.29%	6.90%	$ 141.82 B	11.83%
ABBV	101.97	-56.06	-54.98%	3.22%	$ 370.66 B	5.79%
NVO	10.37	6.26	60.40%	4.21%	$ 196.74 B	37.15%
MRK	31.14	6.06	19.45%	2.95%	$ 278.25 B	13.59%
AZN	27.42	6.01	21.93%	1.74%	$ 284.89 B	17.19%
GILD	17.36	6.83	39.33%	2.48%	$ 160.03 B	30.99%
BMY	16.05	5.81	36.19%	4.36%	$ 116.80 B	15.01%
ZTS	12.41	10.14	81.75%	2.61%	$ 32.80 B	27.79%
REGN	14.80	2.08	14.08%	0.57%	$ 65.49 B	29.65%
HALO	22.81	36.23	158.82%	0.00%	$ 7.96 B	23.13%
AMGN	22.29	18.92	84.87%	3.00%	$ 173.86 B	20.96%
MCK	19.86	-113.39	-570.98%	0.41%	$ 94.57 B	1.18%
HRMY	11.88	1.90	16.00%	0.00%	$ 1.73 B	16.20%
VRTX	25.56	5.73	22.41%	0.00%	$ 110.89 B	35.51%
CAH	30.11	-17.52	-58.20%	1.03%	$ 46.82 B	0.62%
ADMA	11.96	5.07	42.37%	0.00%	$ 1.98 B	32.43%
BIIB	20.56	1.51	7.36%	0.00%	$ 28.21 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

JAZZ Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

Average Investor10 user rating

4.0 (2 people)

United States

23 years

Founded: 2003

2007

Time since IPO - 19 years

1.620

Employees

Jazz Pharmaceuticals PLC (United States) is listed on the Nasdaq and has a market capitalization of $14.23 Billions, with shareholders equity totaling $4.53 Billions.

The company employs approximately 1.620 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Jazz Pharmaceuticals PLC reported $4.44 Billions in revenue, generating net income of $29.49 Millions.

Key financial metrics include a P/E ratio of 482.61, a price-to-book (P/B) ratio of 3.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker JAZZ.

Market cap

$ 14.23 Billions

Net worth

$ 4.53 Billions

$ 4,532,300,000.00

Assets

$ 11.86 Billions

$ 11,859,600,000.00

Total Shares Outstanding

62.00 Millions

62,000,000

Average Daily Trading Volume

$ 918.80 Thousand

$ 918,796.98

Sector

Health Care

Industry

Biotechnology

JAZZ

JAZZ revenue and profits

Financial Results JAZZ

DRAG THE FRAME TO SEE MORE DATA

JAZZ cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 754.68 6,73% (12M)

P/E

19.86

0.41%

ROE

-570.98%

P/BV

-113.39

CAH - Cardinal Health

$ 199.23 32,48% (12M)

P/E

30.11

1.03%

ROE

-58.20%

P/BV

-17.52

JNJ - Johnson & Johnson

$ 229.32 55,38% (12M)

P/E

26.06

2.28%

ROE

25.92%

P/BV

6.75

MRK - Merck & Co.

$ 113.00 50,41% (12M)

P/E

31.14

2.95%

ROE

19.45%

P/BV

6.06

AZN - AstraZeneca

$ 187.46 36,35% (12M)

P/E

27.42

1.74%

ROE

21.93%

P/BV

6.01

ABBV - AbbVie

$ 212.30 20,00% (12M)

P/E

101.97

3.22%

ROE

-54.98%

P/BV

-56.06

NVO - Novo Nordisk

$ 45.07 --30,69% (12M)

P/E

10.37

4.21%

ROE

60.40%

P/BV

6.26

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 754.68 6,73% (12 M)

P/L

19.86

0.41%

ROE

-570.98%

P/VP

-113.39

CAH - Cardinal Health

$ 199.23 32,48% (12 M)

P/L

30.11

1.03%

ROE

-58.20%

P/VP

-17.52

JNJ - Johnson & Johnson

$ 229.32 55,38% (12 M)

P/L

26.06

2.28%

ROE

25.92%

P/VP

6.75

MRK - Merck & Co.

$ 113.00 50,41% (12 M)

P/L

31.14

2.95%

ROE

19.45%

P/VP

6.06

AZN - AstraZeneca

$ 187.46 36,35% (12 M)

P/L

27.42

1.74%

ROE

21.93%

P/VP

6.01

ABBV - AbbVie

$ 212.30 20,00% (12 M)

P/L

101.97

3.22%

ROE

-54.98%

P/VP

-56.06

NVO - Novo Nordisk

$ 45.07 --30,69% (12 M)

P/L

10.37

4.21%

ROE

60.40%

P/VP

6.26

Frequently Asked Questions

What is the price of Jazz Pharmaceuticals (JAZZ) today?

The current price of Jazz Pharmaceuticals (JAZZ) is $ 239.01, representing a 115.29% gain over the past year. The stock began the year trading around $ 170.00 and is currently priced at $ 239.01. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Jazz Pharmaceuticals (JAZZ) pay dividends?

Jazz Pharmaceuticals (JAZZ) did not pay dividends over the past year.

Is Jazz Pharmaceuticals (JAZZ) a good investment?

Jazz Pharmaceuticals (JAZZ) is currently trading at $ 239.01 with a P/E ratio of 482.61. This represents a 8,813% premium compared to its historical average P/E. Over the past year, the stock has gained 115.29 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 115.29%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Jazz Pharmaceuticals (JAZZ) stock?

You can buy Jazz Pharmaceuticals (JAZZ) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol JAZZ and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Jazz Pharmaceuticals (JAZZ) yield today?

Over the past month, Jazz Pharmaceuticals (JAZZ) has returned 17.99% — 115.29% over the past year, and 32.78% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Jazz Pharmaceuticals (JAZZ) today at the current price of $ 239.01 your total investment would be $ 23,901.00.

Based on historical performance, the investment would have grown to approximately:

$ 51,456.46 after 1 year
$ 31,735.75 after 5 years
$ 23,901.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

JAZZ

Jazz Pharmaceuticals PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment JAZZ

review the fundamentals of Jazz Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

United States

23 years

2007

1.620

PROFIT X PRICE JAZZ

Financial Results JAZZ

JAZZ cash flow

Asset, Revenue and Profit Growth - JAZZ

JAZZ balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions